EA202192118A1 - Фармацевтическая композиция, содержащая ацетаминофен и ибупрофен - Google Patents

Фармацевтическая композиция, содержащая ацетаминофен и ибупрофен

Info

Publication number
EA202192118A1
EA202192118A1 EA202192118A EA202192118A EA202192118A1 EA 202192118 A1 EA202192118 A1 EA 202192118A1 EA 202192118 A EA202192118 A EA 202192118A EA 202192118 A EA202192118 A EA 202192118A EA 202192118 A1 EA202192118 A1 EA 202192118A1
Authority
EA
Eurasian Patent Office
Prior art keywords
ibuprofen
pharmaceutical composition
composition containing
containing acetaminophen
acetaminophen
Prior art date
Application number
EA202192118A
Other languages
English (en)
Inventor
Маура Мёрфи
Мэтт Каллахан
Original Assignee
АФТ Фармасьютикалз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by АФТ Фармасьютикалз Лимитед filed Critical АФТ Фармасьютикалз Лимитед
Publication of EA202192118A1 publication Critical patent/EA202192118A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Раскрываются твердые пероральные дозированные формы, содержащие 325 мг ацетаминофена и 97,5 мг ибупрофена или 500 мг ацетаминофена и 150 мг ибупрофена, где ибупрофен характеризуется D50 от 1 до 9 мкм.
EA202192118A 2019-02-27 2020-02-27 Фармацевтическая композиция, содержащая ацетаминофен и ибупрофен EA202192118A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/287,836 US11197830B2 (en) 2019-02-27 2019-02-27 Pharmaceutical composition containing acetaminophen and ibuprofen
PCT/US2020/020112 WO2020176736A1 (en) 2019-02-27 2020-02-27 Pharmaceutical composition containing acetominophen and ibuprofen

Publications (1)

Publication Number Publication Date
EA202192118A1 true EA202192118A1 (ru) 2021-11-18

Family

ID=72140141

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202192118A EA202192118A1 (ru) 2019-02-27 2020-02-27 Фармацевтическая композиция, содержащая ацетаминофен и ибупрофен

Country Status (23)

Country Link
US (4) US11197830B2 (ru)
EP (1) EP3930691A4 (ru)
CN (1) CN113795243A (ru)
AU (4) AU2019268077B2 (ru)
BR (1) BR112021017037A2 (ru)
CA (1) CA3131917A1 (ru)
CL (1) CL2021002252A1 (ru)
CO (1) CO2021011525A2 (ru)
CR (1) CR20210451A (ru)
EA (1) EA202192118A1 (ru)
EC (1) ECSP21072036A (ru)
GB (1) GB2595406B (ru)
IL (1) IL285866A (ru)
JO (1) JOP20210235A1 (ru)
MA (2) MA54028B2 (ru)
MX (1) MX2021010338A (ru)
NZ (1) NZ759337A (ru)
PE (1) PE20220591A1 (ru)
SG (1) SG11202109258WA (ru)
TN (1) TN2021000176A1 (ru)
TW (1) TW202045148A (ru)
UA (1) UA127775C2 (ru)
WO (1) WO2020176736A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
KR20220027194A (ko) * 2019-06-27 2022-03-07 글락소스미스클라인 컨슈머 헬스케어 홀딩스 (유에스) 엘엘씨 신규 이부프로펜 및 아세트아미노펜 조성물

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5148139B2 (ru) 1972-09-30 1976-12-18
AU605538B2 (en) 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
US5260337A (en) 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
ZA959469B (en) 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
JP3982889B2 (ja) 1997-11-28 2007-09-26 あすか製薬株式会社 イブプロフェン含有医薬製剤
US6440983B1 (en) 2000-12-21 2002-08-27 Mary Theresa Frank-Kollman Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
WO2004000284A1 (en) * 2002-06-21 2003-12-31 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
GB0414442D0 (en) 2004-06-28 2004-07-28 Borealis As Zeolite catalysts
GB2431346C (en) 2004-07-07 2010-02-17 Aft Pharmaceuticals Ltd A combination composition comprising paracetamol and ibuprofen
KR20060072839A (ko) 2004-12-23 2006-06-28 김경태 아세트아미노펜과 이부프로펜을 이용하여 통증조절과 해열작용을 하는 주사제
GB0519350D0 (en) 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
WO2008079818A2 (en) 2006-12-21 2008-07-03 Soluprin Pharmaceuticals, Inc. Intravenous administration of water soluble analgesic formulations
JP5148139B2 (ja) 2007-03-12 2013-02-20 パナソニック株式会社 半導体装置及びその製造方法
US20100288665A1 (en) * 2007-07-23 2010-11-18 Kingsway Pharmaceuticals Inc. Therapeutic formulations for the treatment of cold and flu-like symptoms
US20090264530A1 (en) 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method
TR201906742T4 (tr) 2008-10-14 2019-05-21 Aft Pharmaceuticals Ltd Tıbbi bir ürün ve tedavi.
WO2010121328A1 (en) 2009-04-24 2010-10-28 Iceutica Pty Ltd A novel formulation of indomethacin
CN102438600A (zh) 2009-04-24 2012-05-02 伊休蒂卡有限公司 用于改善生物活性物质溶出度特征的方法
US11135188B2 (en) 2009-05-11 2021-10-05 Bayer Healthcare Llc Method and composition to improve absorption of therapeutic agents
AU2011274652B2 (en) 2010-07-07 2013-08-15 Aft Pharmaceuticals Limited A combination composition comprising ibuprofen and paracetamol
CL2010000738A1 (es) 2010-07-08 2011-03-25 Wockhardt Res Centre Suspension farmaceutica oral que comprende desde 100 hasta 500 mg/5ml de paracetamol, desde 40 hasta 80 mg/5ml de ibuprofeno o desde 200 hasta 400 mg/5ml de paracetamol, desde 100 hasta 200 mg/5ml de ibuprofeno y uno o mas excipientes farmaceuticamente aceptables, util para tratar el dolor pre, peri o postoperatorio.
CN107519159A (zh) * 2010-11-04 2017-12-29 阿福特药物有限公司 复方组合物
JP5830412B2 (ja) 2011-03-02 2015-12-09 ライオン株式会社 水難溶性薬物と賦形剤との粉砕物の製造方法、造粒粒子の製造方法、錠剤の製造方法
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen

Also Published As

Publication number Publication date
AU2022201196A1 (en) 2022-03-17
GB202112205D0 (en) 2021-10-13
US20240091160A1 (en) 2024-03-21
EP3930691A4 (en) 2022-11-30
MA62176A1 (fr) 2024-01-31
US20220175680A1 (en) 2022-06-09
MA54028A1 (fr) 2022-06-30
TN2021000176A1 (en) 2023-04-04
CO2021011525A2 (es) 2021-09-20
CN113795243A (zh) 2021-12-14
CL2021002252A1 (es) 2022-04-29
NZ759337A (en) 2023-06-30
UA127775C2 (uk) 2023-12-27
GB2595406A (en) 2021-11-24
JOP20210235A1 (ar) 2023-01-30
SG11202109258WA (en) 2021-09-29
AU2021200634A1 (en) 2021-03-04
PE20220591A1 (es) 2022-04-22
US20230201125A1 (en) 2023-06-29
MX2021010338A (es) 2022-01-07
IL285866A (en) 2021-10-31
WO2020176736A1 (en) 2020-09-03
BR112021017037A2 (pt) 2021-11-09
US11872317B2 (en) 2024-01-16
EP3930691A1 (en) 2022-01-05
US20200268673A1 (en) 2020-08-27
AU2019268077B2 (en) 2021-02-25
US11197830B2 (en) 2021-12-14
CR20210451A (es) 2021-12-02
US11534407B2 (en) 2022-12-27
ECSP21072036A (es) 2021-11-30
AU2024203208A1 (en) 2024-05-30
TW202045148A (zh) 2020-12-16
CA3131917A1 (en) 2020-09-03
MA54028B2 (fr) 2023-10-31
AU2021200634B2 (en) 2022-03-10
GB2595406B (en) 2023-05-10
AU2019268077A1 (en) 2020-09-10

Similar Documents

Publication Publication Date Title
EA202092490A1 (ru) Модуляторы метилмодифицирующих ферментов, композиции и их применения
EA201992116A1 (ru) Фармацевтические составы флороглюцинола и триметилфлороглюцинола
EA201691242A1 (ru) Фармацевтические композиции, содержащие azd9291
EA201792592A1 (ru) Фармацевтические препараты, содержащие тенофовир и эмтрицитабин
PA8809601A1 (es) Combinación anti-retroviral
EA201792591A1 (ru) Фармацевтические препараты
EA202192118A1 (ru) Фармацевтическая композиция, содержащая ацетаминофен и ибупрофен
EA202090542A1 (ru) Высококонцентрированные лекарственные формы придопидина
MA49839B1 (fr) Inhibiteurs bicycliques de la histone déacétylase
EA201991287A1 (ru) Твердые фармацевтические композиции на основе тикагрелора для перорального применения
TR201913472A2 (tr) Vi̇ldagli̇pti̇n ve metformi̇n i̇çeren bi̇r kombi̇nasyon
EA201991286A1 (ru) Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин
WO2018119108A8 (en) Solid pharmaceutical formulations of asimadoline
CY1125762T1 (el) Νεα απο του στοματος σκευασματα βελινοστατης
EA201890929A1 (ru) Низкие дозировки композиций дипиридамола для перорального приема и их использование
EA201992844A1 (ru) Новые пероральные составы на основе белиностата
TR201914406A2 (tr) Sapropteri̇n di̇hi̇droklorür ve en az bi̇r farmasöti̇k eksi̇pi̇yan i̇çeren kati oral farmasöti̇k formülasyonlar
TR201722039A2 (tr) Mesalazi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari
EA201991007A1 (ru) Твердые фармацевтические композиции на основе гидрохлорида луразидона для перорального применения
TR2023017232A2 (tr) 5 mg ve 10 mg melatoni̇n i̇çeren farmasöti̇k formülasyonlar
EA202092800A1 (ru) Фармацевтическая композиция немедленного высвобождения для противовоспалительных лекарственных средств с фамотидином и карбонатом
EA202091611A3 (ru) Не содержащая наполнитель фармацевтическая композиция, содержащая фенозановую кислоту
MX2021014830A (es) Conjugados de compuestos que comprenden nitrogeno heteroaromatico donador de pares de electrones pi.
EA202091127A1 (ru) Фармацевтические композиции, включающие сафинамид
TR201818986A2 (tr) İvabradi̇n ve metoprolol i̇çeren kati oral farmasöti̇k kompozi̇syonlar